Where are we now with hormone replacement therapy?

Reproductive Health Matters

Volumn 12, Issue 24, 2004, Pages 200-203

  McPherson, Klim ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

BREAST CANCER; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DECISION MAKING; ENDOMETRIUM CANCER; HEALTH CARE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; ILLEGITIMACY; INDEPENDENCE; LEARNING; MARKET; MARKETING; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REVIEW;

EID: 7544241195     PISSN: 09688080     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-8080(04)24144-1     Document Type: Article

References (12)

1. Barrett-Connor E Cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. J Clin End Met. 88:2003;4031-4042
2. Writing Group for Women's Health Initiative Investigators Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the women's health initiative randomised controlled trial. JAMA. 288:2002;321-333
3. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the million women study. Lancet. 362:2003;419-427
4. Studd J Complications of hormone replacement therapy in postmenopausal women. J R Soc Med. 85:1992;376-378
5. Michels KB, Manson JE Postmenopausal hormone therapy, a reversal of fortune. Circulation. 107:2003;1830-1833
6. Sackett D The arrogance of preventive medicine. JCMA. 167:2002;363-364
7. Herrington DM, Howard TD From presumed benefit to potential harm - hormone therapy and heart disease. N Engl J Med. 346:2003;519-521
8. Bailar J Hormone replacement therapy and cardiovascular diseases. N Engl J Med. 339;6:2003;521-522
9. Minelli C, Abrams KK, Sutton AJ, Cooper NJ Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ. 328:2004;371-375
10. Shapiro S Risks of estrogen plus progestins therapy; a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric. 6:2003;302-310
11. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestins and the risks of coronary heart disease. N Engl J Med. 349:2003;523-534
12. Tucker G Comments from reviewer. Climacteric. 6:2003;310-314